JavaScript is disabled for your browser. Some features of this site may not work without it.

    Listar

    Todo RIUMAComunidades & ColeccionesPor fecha de publicaciónAutoresTítulosMateriasTipo de publicaciónCentrosEsta colecciónPor fecha de publicaciónAutoresTítulosMateriasTipo de publicaciónCentros

    Mi cuenta

    AccederRegistro

    Estadísticas

    Ver Estadísticas de uso

    DE INTERÉS

    Datos de investigaciónReglamento de ciencia abierta de la UMAPolítica de RIUMAPolitica de datos de investigación en RIUMASHERPA/RoMEODulcinea
    Preguntas frecuentesManual de usoDerechos de autorContacto/Sugerencias
    Ver ítem 
    •   RIUMA Principal
    • Investigación
    • Biología Celular, Genética y Fisiología - (BCGF)
    • BCGF - Contribuciones a congresos científicos
    • Ver ítem
    •   RIUMA Principal
    • Investigación
    • Biología Celular, Genética y Fisiología - (BCGF)
    • BCGF - Contribuciones a congresos científicos
    • Ver ítem

    Neural stem cell signaling by dysregulation leading to cancer

    • Autor
      Tomé, Mercedes
    • Fecha
      2013-12-17
    • Palabras clave
      Gliomas
    • Resumen
      Notch signaling regulates proliferation, differentiation and survival of neural stem cells (NSCs) in the central nervous system. Transformed NSCs are thought to be the origin of brain cancer stem cells and of the more aggressive tumors such as gliomas. Overactive Notch2 signaling has been also associated with gliomas and poor prognosis. Aberrant Notch2 signaling may therefore contribute to the transformation of NSCs and gliomagenesis. In fact, we have previously shown that constitutive upregulation of the Notch2 intracellular domain (N2ICD) in the NSC lineage enhances proliferation and chemoresistance of NSCs. Here, we investigated the mechanism by which N2ICD promotes chemoresistance in NSCs, an acquired feature that likely contributes to transformation and have potential implication in cancer therapy. We performed ex-vivo studies using NSC cultures from transgenic mice that constitutively express N2ICD. These NSCs exhibit etoposide chemoresistance with inhibited mitochondria-caspase pathway and increased expression of pro-survival proteins. Using a pharmacological approach we interestingly show that N2ICD enhances FGF receptor-1 (FGFR1) activity to specifically target AKT-GSK3 signaling pathway to promote chemoresistance in NSCs. Finally we found that the chemoresistance ability of glioma cell lines is also dependent on Notch2 signaling which supports a role of Notch2 in NSC transformation. We have identified a molecular mechanism through which aberrant Notch2 signaling could contribute to NSC transformation and revealed new aspects of signaling crosstalks that could be of relevance for targeted therapy efficacy.
    • URI
      http://hdl.handle.net/10630/6799
    • Compartir
      RefworksMendeley
    Mostrar el registro completo del ítem
    Ficheros
    Resumen conferencia Mercedes Tome.pdf (28.59Kb)
    Colecciones
    • BCGF - Contribuciones a congresos científicos

    Estadísticas

    Ver Estadísticas de uso
    Buscar en Dimension
    REPOSITORIO INSTITUCIONAL UNIVERSIDAD DE MÁLAGA
    REPOSITORIO INSTITUCIONAL UNIVERSIDAD DE MÁLAGA
     

     

    REPOSITORIO INSTITUCIONAL UNIVERSIDAD DE MÁLAGA
    REPOSITORIO INSTITUCIONAL UNIVERSIDAD DE MÁLAGA